These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14742994)

  • 21. Soluble interleukin-2 receptor (sIL-2R) levels in renal transplantation: comparison between clinical and laboratory analysis.
    Montagnino G; Tarantino A; Grignani S; Braga M; Ponticelli C
    Clin Transplant; 1995 Feb; 9(1):25-30. PubMed ID: 7742579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strong inflammatory cytokine response in male and strong anti-inflammatory response in female kidney transplant recipients with urinary tract infection.
    Sadeghi M; Daniel V; Naujokat C; Wiesel M; Hergesell O; Opelz G
    Transpl Int; 2005 Feb; 18(2):177-85. PubMed ID: 15691270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A single-dose daclizumab induction protocol in renal allograft recipients: a Chinese single center experience.
    Ji SM; Li LS; Cheng Z; Cheng DR; Sun QQ; Chen JS; Sha GZ; Liu ZH
    Transplant Proc; 2007 Jun; 39(5):1396-401. PubMed ID: 17580147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional assessment of immune markers of graft rejection: a comprehensive study in live-related donor renal transplantation.
    Panigrahi A; Deka R; Bhowmik D; Dash SC; Tiwari SC; Guleria S; Mehta SN; Mehra NK
    Clin Transplant; 2006; 20(1):85-90. PubMed ID: 16556160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of epidermolysis bullosa acquisita with the humanized anti-Tac mAb daclizumab.
    Egan CA; Brown M; White JD; Yancey KB
    Clin Immunol; 2001 Nov; 101(2):146-51. PubMed ID: 11683573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
    Bien E; Balcerska A
    Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. One-year outcomes in simultaneous kidney-pancreas transplant recipients receiving an alternative dosing regimen of daclizumab.
    Stratta RJ; Alloway RR; Lo A; Hodge EE;
    Transplant Proc; 2004 May; 36(4):1080-1. PubMed ID: 15194375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subclinical inflammation in renal transplant recipients: impact of cyclosporine microemulsion versus tacrolimus.
    Lauzurica R; Pastor MC; Bayes B; Malumbres S; Homs M; Llopis MA; Bonet J; Romero R
    Transplant Proc; 2007 Sep; 39(7):2170-2. PubMed ID: 17889127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.
    Bleesing J; Prada A; Siegel DM; Villanueva J; Olson J; Ilowite NT; Brunner HI; Griffin T; Graham TB; Sherry DD; Passo MH; Ramanan AV; Filipovich A; Grom AA
    Arthritis Rheum; 2007 Mar; 56(3):965-71. PubMed ID: 17328073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The weight of pharmacokinetic parameters for mycophenolic acid in prediction of rejection outcome: the receiver operating characteristic curve analysis.
    Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Ostrowska J; Gralak B; Majchrzak J
    Transplant Proc; 2006; 38(1):86-9. PubMed ID: 16504671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial.
    Busse WW; Israel E; Nelson HS; Baker JW; Charous BL; Young DY; Vexler V; Shames RS;
    Am J Respir Crit Care Med; 2008 Nov; 178(10):1002-8. PubMed ID: 18787222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two doses of daclizumab with delayed introduction of low-dose tacrolimus in elderly recipients of cadaveric renal transplants from donors >55 years of age.
    Osuna A; Gentil MA; Capdevila L; Cantarell C; Mazuecos A; Pereira P; Rodríguez-Algarra G; González-Molina M;
    Transplant Proc; 2005 Apr; 37(3):1438-40. PubMed ID: 15866630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
    Sundberg AK; Rohr MS; Hartmann EL; Adams PL; Stratta RJ
    Clin Transplant; 2004; 18 Suppl 12():61-6. PubMed ID: 15217410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-CD25 antibody (daclizumab) maintenance therapy in pancreas transplantation.
    Kirchner VA; Suszynski TM; Radosevich DM; Humar A; Dunn TB; Hill MJ; Finger EB; Sutherland DE; Kandaswamy R
    Transplant Proc; 2010; 42(6):2003-5. PubMed ID: 20692392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of anti-IL-2Ralpha antibody on IL-2-induced Jak/STAT signaling.
    Tkaczuk J; Yu CL; Baksh S; Milford EL; Carpenter CB; Burakoff SJ; McKay DB
    Am J Transplant; 2002 Jan; 2(1):31-40. PubMed ID: 12095053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is the determination of the soluble interleukin-2 receptor after application of interleukin-2 receptor antibodies still appropriate for immunological monitoring after renal transplantation?
    Hamza A; Fischer K; Loertzer H; Fornara P
    Urol Int; 2006; 77(3):232-9. PubMed ID: 17033211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic and pharmacodynamic studies of one or two doses of daclizumab in renal transplantation.
    Vincenti F; Pace D; Birnbaum J; Lantz M
    Am J Transplant; 2003 Jan; 3(1):50-2. PubMed ID: 12492710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicenter analysis of the significance of HLA matching on outcomes after kidney-pancreas transplantation.
    Lo A; Stratta RJ; Alloway RR; Hodge EE;
    Transplant Proc; 2005 Mar; 37(2):1289-90. PubMed ID: 15848699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maternal serum levels of interferon-gamma and interleukin-2 soluble receptor-alpha predict the outcome of early IVF pregnancies.
    Fasouliotis SJ; Spandorfer SD; Witkin SS; Schattman G; Liu HC; Roberts JE; Rosenwaks Z
    Hum Reprod; 2004 Jun; 19(6):1357-63. PubMed ID: 15105393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.